![]() |
|
|
Vol. 27, Issue 9, 1092-1097, September 1999
Department of Pharmacy, King's College London, London, United
Kingdom
The routes of metabolism of
S-carboxymethyl-L-cysteine in humans are
dependent on the time of dosing. Administration of 750 mg of
S-carboxymethyl-L-cysteine (Day 1) during
the day at 8:00 AM followed by a 8:00 AM to 4:00 PM urine
collection revealed that
S-carboxymethyl-L-cysteine
S-oxide was the major urinary metabolite produced. The
4:00 PM to midnight urine collection resulted in
S-(carboxymethylthio)-L-cysteine being
identified as the major urinary metabolite. However, the administration
of 750 mg of S-carboxymethyl-L-cysteine (day
15) during the night at midnight and analysis of the midnight to 8:00
AM urine collection found that thiodiglycolic acid was the major
urinary metabolite, whereas thiodiglycolic S-oxide was
identified as the major urinary metabolite in the 8:00 AM to 4:00 PM
urine collection. A diurnal variation in the metabolism of
S-carboxymethyl-L-cysteine was seen and, in
particular, the timing of
S-carboxymethyl-L-cysteine administration
had a profound effect on the identity of urinary S-oxide
metabolites produced. After administration at 8:00 AM the urinary
S-oxides produced were
S-carboxymethyl-L-cysteine S-oxide and
S-methyl-L-cysteine S-oxide
but at midnight the major urinary S-oxide metabolite
produced was thiodiglycolic acid S-oxide.
This article has been cited by other articles:
![]() |
G. B. Steventon and S. C. Mitchell The sulphoxidation of S-carboxymethyl-L-cysteine in COPD. Eur. Respir. J., April 1, 2006; 27(4): 865 - 866. [Full Text] [PDF] |
||||